Summarized by Masters of Longevity from Aging Cell.
Discover a research article about identifying flavonoid-based senotherapeutics through phenotypic screening; it previews findings on cellular senescence and broader healthspan effects.
Key Takeaways
- Phenotypic drug screening identified multiple novel flavonoid compounds with senotherapeutic activity in cell assays.
- Lead flavonoids reduced established senescence markers and proinflammatory SASP factors in treated cell models.
- Treatment improved multiple organismal healthspan markers in preclinical models without reported acute toxicity.
